河北省成年居民物质所致精神障碍的影响因素分析

doi:10.19485/j.cnki.issn2096-5087.2021.06.003

预防医学

2021, Vol. 33

Issue (6): 551-557 DOI: 10.19485/j.cnki.issn2096-5087.2021.06.003

论著

本期目录 | 过刊浏览 | 高级检索

河北省成年居民物质所致精神障碍的影响因素分析

贾宏学¹, 张云淑², 栗克清²

1.河北大学公共卫生学院,河北保定 071000;
2.河北省精神卫生中心科教处

Influencing factors for substance-induced psychotic disorders among adultsin Hebei Province

JIA Hongxue, ZHANG Yunshu, LI Keqing

College of Public Health, Hebei University, Baoding, Hebei 071000, China

摘要
参考文献
相关文章
Metrics

全文: PDF(902 KB)
输出: BibTeX | EndNote (RIS)

摘要目的了解河北省成年居民物质所致精神障碍情况,并分析其影响因素,为制订物质所致精神障碍防制策略提供依据。方法采用多阶段分层随机抽样方法,在河北省城市和农村逐层选取≥18岁常住居民为调查对象,采用自行设计的一般情况问卷收集人口学资料,采用一般健康问卷12项（GHQ-12）和8个有关精神障碍危险因素问卷收集物质所致精神障碍情况;采用多因素Logistic回归模型分析物质所致精神障碍的影响因素。结果发放问卷23 675份,回收有效问卷20 884份,回收有效率为88.21%。居民物质所致精神障碍终生患病率加权后为6.20%,其中酒精、镇静剂/催眠药/抗焦虑药和其他物质所致精神障碍的终生患病率加权后分别为5.93%、0.24%和0.04%。多因素Logistic回归分析结果显示,年龄（35~<45岁,OR=1.582,95%CI：1.091~2.292;45~<60岁,OR=2.185,95%CI：1.524~3.132;≥60岁,OR=2.061,95%CI：1.422~2.986）、男性（OR=10.832,95%CI：8.265~14.196）、居住在城市（OR=1.431,95%CI：1.202~1.703）、非贫困家庭（OR=2.291,95%CI：1.652~3.177）、有躯体疾病（OR=2.028,95%CI：1.678~2.452）和有遗传病史（OR=1.574,95%CI：1.181~2.098）与物质所致精神障碍存在统计学关联。结论河北省成年居民物质所致精神障碍终生患病率为6.20%,患病风险与年龄、性别、地区、家庭经济状况、躯体疾病史和遗传病史相关。

	服务

	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	贾宏学
	张云淑
	栗克清

关键词 ：物质所致精神障碍, 患病率, 影响因素

Abstract：Objective To investigate the status and influencing factors of substance-induced psychotic disorders in residents over 18 years old in Hebei Province, and to provide evidence for the prevention and control of substance-induced psychotic disorders. Methods Using multi-stage stratified random sampling method, the permanent residents aged 18 years and over were selected from urban and rural areas in Hebei Province. The demographic data was collected, the 12-Item General Health Questionnaire ( GHQ-12 ) and eight risk factors about mental disorder questionnaire were used to find out mental disorders. The multivariate logistic regression model was conducted to analyze the influencing factor for substance-induced psychotic disorders. Results A total of 23 675 questionnaires were sent out, 20 884 were valid ( 88.20% ).The weighted lifetime prevalence rates of substance-induced psychotic disorders, alcohol-related disorders, sedatives/hypnotics/anti-anxiety disorders and other substance-induced psychotic disorders were 6.20%, 5.93%, 0.24% and 0.04%, respectively. Multivariate logistic regression analysis showed that age ( 35-<45, OR=1.582, 95%CI: 1.091-2.292; 45-<60, OR=2.185, 95%CI: 1.524-3.132; ≥60, OR=2.061, 95%CI: 1.422-2.986 ), males ( OR=10.832, 95%CI: 8.265-14.196 ), urban area (OR=1.431, 95%CI: 1.202-1.703 ), non-poor family ( OR=2.291, 95%CI: 1.652-3.177 ), physical diseases ( OR=2.028, 95%CI: 1.678-2.452 ) and genetic history ( OR=1.574, 95%CI:1.181-2.098 ) were the influencing factors for substance-induced psychotic disorders. Conclusion The lifetime prevalence of substance-induced psychotic disorders among residents aged 18 years and over in Hebei Province is 6.20%, which is mainly related to age, gender, region, family economic situation, physical disease history and genetic history.

Key words： substance-induced psychotic disorders prevalence influencing factors

收稿日期: 2020-11-30 修回日期: 2021-03-10

中图分类号:

R179

基金资助:河北省重点研发计划(182777194)

作者简介: 贾宏学,硕士,主要从事精神障碍流行病学调查工作

通信作者: 栗克清,E-mail:like1002@sina.com

引用本文:

贾宏学, 张云淑, 栗克清. 河北省成年居民物质所致精神障碍的影响因素分析[J]. 预防医学, 2021, 33(6): 551-557.
JIA Hongxue, ZHANG Yunshu, LI Keqing. Influencing factors for substance-induced psychotic disorders among adultsin Hebei Province. Preventive Medicine, 2021, 33(6): 551-557.

链接本文:

http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2021.06.003 或 http://www.zjyfyxzz.com/CN/Y2021/V33/I6/551

[1] KUNREUTHER E.Autism spectrum disorder and substance use disorder:a dual diagnosis hiding in plain sight[J].Child Adolesc Psychiatr Clin N Am,2020,29(3):467-481.
[2] ZHANG H X,JI J L.Prevalence of mental disorders in China[J].Lancet Psychiatry,2019,6(3):188-189.
[3] 栗克清,崔泽,崔利军,等.河北省精神障碍的现况调查[J].中华精神科杂志,2007,40(1):36-40.
[4] 李建彬,高莉,郭向娇,等.郑州市居民二手烟暴露及危害认知情况调查[J].预防医学,2020,32(5):455-459.
[5] ANJARA S G, BONETTO C, BORTEL T V, et al.Using the GHQ-12 to screen for mental health problems among primary care patients: psychometrics and practical considerations[J].Int J Ment Health Syst,2020,14(1):1-7.
[6] PHILLIPS M R,ZHANG J X,SHI Q C,et al.Prevalence,treatment, and associated disability of mental disorders in four provinces in China during 2001-2005: an epidemiological survey[J].Lancet,2009,373(9680):2041-2053.
[7] VENTURA J, LIBERMAN R P, GREEN M F, et al.Training and quality assurance with the structured clinical interview for DSM-IV (SCID-I/P)[J].Psychiatry Res,1998,79(2):163-173.
[8] ZHANG Y S, RAO W W, CUI L J, et al.Prevalence of major depressive disorder and its socio-demographic correlates in the general adult population in Hebei province,China[J].J Affect Disord,2019,252:92-98.
[9] 金金,何燕玲,周亮,等.精神病症状维度评定量表中文版的效度和信度[J].中国心理卫生杂志,2020,34(11):932-939.
[10] HUANG Y Q,WANG Y,WANG H,et al.Prevalence of mental disorders in China: a cross-sectional epidemiological study[J].Lancet Psychiatry,2019,6(3):211-224.
[11] 李建华. 我国物质成瘾心理行为治疗的现状、挑战及应对策略[J].中国药物滥用防治杂志,2019,25(2):76-81.
[12] 田国娇,张炳智,高茹,等.芦山4·20地震5年后雅安地区酒精使用障碍流行病学调查[J].中国药物依赖性杂志,2020,29(6):469-473.
[13] 廖震华,王文强,丁丽君,等.厦门市不同人群心境障碍、焦虑障碍和物质相关精神障碍现况调查[J].中国职业医学,2014,41(1):46-51.
[14] 石锦娟. 陕西、河南、甘肃三省精神障碍流行病学调查及对比分析[D].西安:第四军医大学,2015.
[15] MCHUGH R K,GEYER R B,CHASE A R,et al.Sex differences in benzodiazepine misuse among adults with substance use disorders.[J/OL].Addict Behav,2021,112:106608[2021-03-10].https://www.sciencedirect.com/science/article/abs/pii/S0306460320307383?via%3Dihub.DOI:10.1016/j.addbeh.2020.106608.
[16] ANDERSSON H W,NORDFJÆRN T.Factors associated with quality of life trajectories among inpatients treated for alcohol use disorders:a prospective cohort study.[J/OL].Addict Behav Rep,2020,12:100285[2021-03-10].https://www.sciencedirect.com/science/article/pii/S2352853220301000?via%3Dihub.DOI:10.1016/j.abrep.2020.100285
[17] 李凤娟,孙经,何健,等.河南省青少年物质成瘾行为现况及影响因素分析[J].中国公共卫生,2018,34(4):497-500.
[18] 润海燕,李英,王爱民,等.苯丙胺类、阿片类和酒依赖者住院后结局与影响因素研究[J].内蒙古医学杂志,2020,52(5):516-520.

[1]	刘晶芝, 胡燕燕, 张学伟, 阿依努尔. 新疆阿勒泰农牧区哈萨克族小学生贫血调查[J]. 预防医学, 2023, 35(9): 807-810.
[2]	朱思懿, 洪航, 边学燕, 许国章. 慢性肾脏病流行病学研究进展[J]. 预防医学, 2023, 35(9): 770-773.
[3]	俞素芬, 蒋青林, 戴杰. 2012—2021年吴兴区新报告HIV/AIDS病例晚发现及影响因素分析[J]. 预防医学, 2023, 35(9): 796-799.
[4]	方柯红, 朱冰, 黄利明, 张旭慧, 刘辉. 杭州市成年居民营养健康知识调查[J]. 预防医学, 2023, 35(8): 710-713.
[5]	周星缘, 洪航, 方挺, 许国章. 肺炎流行病学研究进展[J]. 预防医学, 2023, 35(8): 682-686.
[6]	柏旭, 苏洁, 李凤, 徐倩, 沈源, 肖凌凤. 我国成人糖尿病视网膜病变影响因素的Meta分析[J]. 预防医学, 2023, 35(7): 595-601.
[7]	王梦琴, 柴荟琳, 郭宇燕, 任敬娟, 梁瑞峰. 山西省农村居民高血压防治知识、态度、行为调查[J]. 预防医学, 2023, 35(7): 563-569.
[8]	杨冰声, 曹承建. 杭州市美沙酮维持治疗患者脱失的影响因素分析[J]. 预防医学, 2023, 35(6): 522-525.
[9]	姜海波, 洪航, 周健, 李继革, 史宏博, 谭诗文, 褚堃, 张丹丹. 宁波市HIV/AIDS病例新型毒品使用情况调查[J]. 预防医学, 2023, 35(6): 470-474.
[10]	彭晶, 傅文婷, 杨秀琳. 甘南藏族自治州老年人群健康素养调查[J]. 预防医学, 2023, 35(6): 546-550.
[11]	常倩, 王维丹, 钱建军, 胡华锋. 绍兴市严重精神障碍患者健康体检的影响因素分析[J]. 预防医学, 2023, 35(6): 491-495.
[12]	曾龙武, 唐晓鸿, 张素霞, 刘强, 梁朝聪, 唐漫漫. 结直肠癌化疗患者照护人疾病不确定感影响因素分析[J]. 预防医学, 2023, 35(5): 444-447.
[13]	卢小敏, 赵继娟, 孙中友, 张学艳, 陈盛兰. 盐城市儿童青少年健康危险行为聚集情况调查[J]. 预防医学, 2023, 35(4): 331-334.
[14]	吴子怡, 闫馨, 艾丽孜热·艾尼瓦尔, 杜文琪. 孕期增重过度的影响因素分析[J]. 预防医学, 2023, 35(4): 345-349.
[15]	王倩倩, 章涛, 李傅冬, 林君芬, 何凡, 俞敏, 曹亦菲. 老年人群白内障的影响因素分析[J]. 预防医学, 2023, 35(4): 311-315.

Viewed

Full text

Abstract

Cited

Shared

Discussed